McCann, Gerry P.

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology

Hormonal Regulation and HypertensionBlood Pressure and Hypertension Studies

Cited by 347

Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension

McCann, G. P., Gan, C. T., Beek, A. M., Niessen, H. W. M., Noordegraaf, A. V., & van Rossum, A. C. (2007) · American Journal of Roentgenology

Pulmonary Hypertension Research and TreatmentsCardiomyopathy and Myosin Studies

Cited by 147

Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure with Preserved Ejection Fraction

Kanagala, P., Cheng, A. S. H., Singh, A., Khan, J. N., Gulsin, G. S., Patel, P., Gupta, P., Arnold, J. R., Squire, I. B., Ng, L. L., et al. (2019) · JACC. Cardiovascular imaging

Cardiac Imaging and DiagnosticsCardiomyopathy and Myosin Studies

Cited by 126

Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document

Dweck, M. R., Loganath, K., Bing, R., Treibel, T. A., McCann, G. P., Newby, D. E., Leipsic, J., Fraccaro, C., Paolisso, P., Cosyns, B., et al. (2023) · European Heart Journal - Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsCardiac Imaging and Diagnostics

Cited by 79

Associations of Sedentary Time with Fat Distribution in a High-Risk Population

HENSON, J., EDWARDSON, C. L., MORGAN, B., HORSFIELD, M. A., BODICOAT, D. H., BIDDLE, S. J. H., GORELY, T., NIMMO, M. A., MCCANN, G. P., KHUNTI, K., et al. (2015) · Medicine & Science in Sports & Exercise

Physical Activity and HealthAdipokines, Inflammation, and Metabolic Diseases

Cited by 39

Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial

Ahmad, E., Waller, H. L., Sargeant, J. A., Webb, M. A., Htike, Z. Z., McCann, G. P., Gulsin, G., Khunti, K., Yates, T., Henson, J., et al. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 27

Initiation of New Glucose-Lowering Therapies May Act to Reduce Physical Activity Levels: Pooled Analysis From Three Randomized Trials

Yates, T., Sargeant, J. A., King, J. A., Henson, J., Edwardson, C. L., Redman, E., Gulsin, G. S., Brady, E. M., Ahmad, E., Stensel, D. J., et al. (2022) · Diabetes Care

Diabetes Treatment and ManagementPhysical Activity and Health

Cited by 9